|
Re: HDL from an Alzheimer's disease perspective
|
1
|
Resverlogix Corp.
|
Jun 27, 2019 10:22AM
|
|
Re: HDL from an Alzheimer's disease perspective
|
4
|
Resverlogix Corp.
|
Jun 27, 2019 10:08AM
|
|
HDL from an Alzheimer's disease perspective
|
5
|
Resverlogix Corp.
|
Jun 27, 2019 08:41AM
|
|
Zenith Epigenetics Announces Dosing of First Patient in Triple Negative Breast Cancer Trial with Pfizer
|
3
|
Zenith Epigenetics
|
Jun 27, 2019 08:36AM
|
|
Re: wondering if Dart & co...
|
2
|
Resverlogix Corp.
|
Jun 26, 2019 01:20PM
|
|
Re: No ESC 2019 Late Breaker
|
7
|
Resverlogix Corp.
|
Jun 26, 2019 11:00AM
|
|
No ESC 2019 Late Breaker
|
7
|
Resverlogix Corp.
|
Jun 26, 2019 09:25AM
|
|
Bioasis Announces FDA Response to Pre-IND Submission
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 25, 2019 05:09PM
|
|
Re: Reminds me of.......
|
3
|
Resverlogix Corp.
|
Jun 25, 2019 02:24PM
|
|
Re: Reminds me of.......
|
5
|
Resverlogix Corp.
|
Jun 25, 2019 10:57AM
|
|
Re: Patent Applications in U.S. and Europe
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jun 25, 2019 06:55AM
|
|
Bioasis Announces Allowances of Patent Applications in the U.S. and Europe Relating to xB3 Platform Technology and Key Therapeutic Indications
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 25, 2019 06:52AM
|
|
Re: Any forced selling going on?
|
1
|
Resverlogix Corp.
|
Jun 24, 2019 09:03PM
|
|
Re: 2019 Potential Events
|
1
|
Resverlogix Corp.
|
Jun 24, 2019 05:28PM
|
|
Re: How should the company be actng just about now,..
|
4
|
Resverlogix Corp.
|
Jun 24, 2019 02:59PM
|
|
Re: 2019 Potential Events
|
2
|
Resverlogix Corp.
|
Jun 24, 2019 02:15PM
|
|
Re: Probability of Phase 3 trial success
|
6
|
Resverlogix Corp.
|
Jun 23, 2019 12:26PM
|
|
Re: I added a few!
|
2
|
Resverlogix Corp.
|
Jun 22, 2019 08:57AM
|
|
Re: SP Consolidation
|
4
|
Resverlogix Corp.
|
Jun 21, 2019 01:26PM
|
|
Re: SP Consolidation
|
4
|
Resverlogix Corp.
|
Jun 21, 2019 12:41PM
|
